<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
January 31, 2000
----------------
(Report Date of Earliest Event Reported)
Millennium Pharmaceuticals, Inc.
--------------------------------
(Exact name of Registrant as Specified in its Charter)
DELAWARE 0-28494 04-3177038
- ---------------------------- ----------- -------------------
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)
75 Sidney Street, Cambridge, Massachusetts 02139
- --------------------------------------------------------------------------------
(Address of Principal Executive Offices) Zip Code)
Registrant's telephone number, including area code: (617) 679-7000
- --------------------------------------------------------------------------------
(Former Name or Former Address if Changed Since Last Report)
<PAGE>
ITEM 5: OTHER EVENTS
On January 31, 2000, the Board of Directors of Millennium
Pharmaceuticals, Inc. (the "Company") fixed the date, time and place of the 2000
Annual Meeting of Stockholders as Wednesday, April 12, 2000 at 2:00 p.m., local
time, at the offices of Hale and Dorr LLP, 60 State Street, Boston,
Massachusetts. If a stockholder of the Company wishes to present a proposal
before the 2000 Annual Meeting, such stockholder must give written notice to the
Secretary of the Company, 75 Sidney Street, Cambridge, MA 02139, no later than
the close of business on February 20, 2000.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
February 9, 2000 MILLENNIUM PHARMACEUTICALS, INC.
/s/ Kevin P. Starr
-----------------------------
Kevin P. Starr
Chief Financial Officer
2
